Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Adis journals on behalf of, Cruz, Barbara D, Barbosa, Mariana M, Torres, Lucas L, Azevedo, Pamela S, Silva, Vânia E A, Godman, Brian, Alvares-Teodoro, Juliana
Format:	Bild
Sprache:	eng
Schlagworte:	Cancer Cancer Therapy (excl. Chemotherapy and Radiation Therapy) FOS: Clinical medicine Medicine Oncology and Carcinogenesis not elsewhere classified Respiratory Diseases
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.
DOI:	10.6084/m9.figshare.14605395